Obstructive Lung Disease Archives - MPR

Obstructive Lung Disease

FDA Approves Treatment for Systemic Sclerosis-Associated Interstitial Lung Disease

The Food and Drug Administration (FDA) has approved Ofev (nintedanib; Boehringer Ingelheim) capsules as the first FDA-approved treatment to slow the rate of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD).  The approval was based on results from the 52-week, randomized, double-blind, placebo-controlled phase 3 SENSCIS trial that evaluated the…